Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: Initial results

Diagnostic and Interventional Radiology

Volumn 19, Issue 4, 2013, Pages 294-298

  Naswa, Niraj ^a   Sharma, Punit ^a   Soundararajan, Ramya ^a   Patnecha, Manish ^a   Lata, Sneh ^a   Kumar, Rakesh ^a   Malhotra, Arun ^a   Bal, Chandrasekhar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

[1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID] 1 SODIUM TRIIODIDE OCTREOTIDE GA 68; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PREOPERATIVE EVALUATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

ADRENAL GLAND NEOPLASMS; ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MULTIMODAL IMAGING; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879542237     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.5152/dir.2013.048     Document Type: Article

References (11)

1. Bilimoria KY, Shen WT, Elaraj D, et al. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 2008; 113:3130-3136. [CrossRef]
2. Copeland PM. The incidentally discovered adrenal mass. Ann Surg 1984; 199:116-122. [CrossRef]
3. Slattery JM, Blake MA, Kalra MK, et al. Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol 2006; 187:21-24. [CrossRef]
4. Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003; 169:5-11. [CrossRef]
5. Nunes ML, Rault A, Teynie J, et al. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning. World J Surg 2010; 34:1506-1510. [CrossRef]
6. Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 1989; 171:675-680.
7. Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001; 42:1795-1799.
8. Naswa N, Sharma P, Nazar AH, et al. Prospective evaluation of (68)Ga-DOTANOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Eur Radiol 2012; 22:710-719. [CrossRef]
9. Kumar R, Xiu Y, Yu JQ, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004; 45:2058-2062.
10. Zhernosekov KP, Filosofov DV, Baum RP, et al. Processing of generator-produced 68Ga for medical application. J Nucl Med 2007; 48:1741-1748. [CrossRef]
11. Shuklin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET. Radiology 1999; 212:35-41.